LifeArc

We’re delighted to feature in @MoneyWeeks’ cover story on the growing “healthspan” economy. Giovanna Lalli talks about our work developing blood-based diagnostics to support earlier, less invasive Alzheimer’s diagnosis and faster access to treatment. 🔗t.ly/cKPEs

This year's #ClinicalTrialsDay theme, "Research Rising", reflects our commitment to bringing more promising innovations to the clinic, driving progress so that patients with rare diseases can have access to the tests and treatments they urgently need. 🔗 t.ly/YhRRG

Health data is key to unlocking rare disease treatments, but fragmentation is slowing progress. At #LATSS2026, Melanie Ivarsson set out a vision for a UK health data service to support research and improve access to clinical trials. Stay tuned for recordings from the summit.

"Science is no longer the limiting factor. The system is. And the system is something we – together – have the power to redesign." A rallying call from our CEO, Sam Barrell, as she opened the LifeArc Translational Science Summit 2026.

What an incredible day we had at #LATSS2026 yesterday – thanks to everyone who attended and participated in such thoughtful discussions. Look out for the session recordings coming soon.

🎬 That's a wrap on #LATSS2026! Seeing so many scientists, experts, policy makers and innovators together discussing translation and life sciences has been truly inspiring. Thanks to all who attended and we look forward to seeing you again next year.

Great Day at @lifearc1 Translational Science Summit. Some fantastic presentations. @MPSSocietyUK got a mention!

Today at #LATSS2026, Julie Vitarello emphasised the pressing need for a redesign of the system so that more children with rare genetic diseases can access today's life-changing technology.

It's been brilliant seeing connections being made and strengthened today at #LATSS2026 in our break-out areas between sessions.

Huge interest in the #LATSS2026 pro/con debate on AI as a medical device, with the session even spilling into an overflow room.

A strong opening set of plenary sessions at #LATSS2026. It was great to hear Reed Jobs of Yosemite talking about cutting-edge biotech therapies and the critical need for research funding.

Our CEO, Sam Barrell, opened #LATSS2026 with a focus on collaboration, translation and real‑world impact.

The 2026 LifeArc Translational Science Summit is about to kick off! Join the conversation here using #LATSS2026

Our CEO Sam Barrell spoke with the @NewStatesman about the human impact of rare diseases, the barriers to new tests and treatments, and why greater collaboration is essential for making a real difference for people living with rare conditions worldwide.

The wait is almost over – the LifeArc Translational Science Summit is back tomorrow for 2026. Follow along using #LATSS2026 to catch all the highlights from a packed agenda featuring expert speakers and panel discussions.

The #LongitudePrizeOnALS has awarded £2 million across 20 global teams to incentivise the use of AI to transform #DrugDiscovery for #ALS. We are proud to help fund this global challenge: bit.ly/4tCWpcH @mndassoc @Challenge_Works

🔬 We're looking for senior scientific leaders to join us. Two leadership opportunities are now open to help shape impactful drug discovery programmes tackling urgent unmet medical needs. Learn more and apply here: lifearc.org/careers/curren…

Professors Jenna Gregory and Mathew Horrocks’ lab at @aberdeenuni is exploring the use of a synthetic molecule to detect accumulation of TDP-43 in faecal samples. We’re supporting the project via our Primer Fund to improve diagnosis of ALS in primary care:t.ly/KyRR4

No one understands the complex challenges of chronic lung conditions better than those with lived experience. In this video, four individuals share their stories, perspectives and hopes for progress that can be made in the future: youtube.com/watch?v=7jz2sn… @asthmalunguk

CognoMND is a digital tool that could allow people with motor neuron disease to be assessed for cognitive and behavioural changes from the comfort of their homes. This could support earlier detection of changes and better care management. 🔗Learn more: t.ly/m_T4O